Tech Company Financing Transactions

Biolinq Funding Round

Alpha Wave Ventures, Aphelion Capital and AXA IM Alts participated in a $100 million Series C funding round for Biolinq. This VC investment round was announced by the company on 4/22/2025.

Transaction Overview

Company Name
Biolinq
Announced On
4/22/2025
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Series C
Investors

Alpha Wave Ventures (Lead Investor) (Rick Gerson)

Aphelion Capital

AXA IM Alts

Features Capital

Hikma Ventures

LifeSci Venture Partners

M Ventures

RiverVest Venture Partners (Nancy Hong)

Taisho Pharmaceutical

Proceeds Purpose
The funding will support Biolinq through the US regulatory approval process as the company prepares to bring the first autonomous intradermal glucose sensor to market. Biolinq's initial product is a wearable biosensor powered by an array of tiny electrochemical sensors that measure glucose levels continuously just beneath the skin's surface.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4535 Towne Centre Ct. 200
San Diego, CA 92121
USA
Phone
(510) 847-9655
Website
www.biolinq.me
Email Address
[email protected]
Overview
Biolinq is a digital health company developing a skin-applied, minimally-invasive electrochemical biosensor platform which analyzes biomarkers in the interstitial fluid to provide actionable health information.
Profile
Biolinq LinkedIn Company Profile
Social Media
Biolinq Company Twitter Account
Company News
Biolinq News
Facebook
Biolinq on Facebook
YouTube
Biolinq on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jared Tangney
  Jared Tangney LinkedIn Profile  Jared Tangney Twitter Account  Jared Tangney News  Jared Tangney on Facebook
Chief Technical Officer
Joshua Windmiller
  Joshua Windmiller LinkedIn Profile  Joshua Windmiller Twitter Account  Joshua Windmiller News  Joshua Windmiller on Facebook
VP - Regulatory Affairs
Thomas Peyser
  Thomas Peyser LinkedIn Profile  Thomas Peyser Twitter Account  Thomas Peyser News  Thomas Peyser on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/22/2025: Capably venture capital transaction
Next: 4/22/2025: Reusables.com venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to document every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2025. Gaebler Ventures. All rights reserved.